GTS Securities’s Beam Therapeutics BEAM Stock Holding History

GTS Securities’s Portfolio BEAM Stock Details BEAM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-9,755	Closed	-$232K	–	1379
2026 Q1	$232K	Buy	+9,755	New	+$271K	0.01%	1268
2025 Q4	–	Sell	-23,032	Closed	-$559K	–	1398
2025 Q3	$559K	Buy	+23,032	New	+$458K	0.02%	672

Other funds holding BEAM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.75B AUM 33.73% 1-Year Est. Return

GTS Securities's BEAM Position: Q2 2026 in Review

GTS Securities sold out of Beam Therapeutics (BEAM) in Q2 2026, closing a stake of 9,755 shares — an estimated $232K sold.

GTS Securities first reported a position in BEAM in Q3 2025 and held it in 2 quarters. The position peaked at $559K in Q3 2025. 277 funds tracked by Wall St. Rank hold BEAM as of Q2 2026.

GTS Securities reported no remaining Beam Therapeutics position as of Q2 2026 after selling out during the quarter.
GTS Securities sold 9,755 Beam Therapeutics shares in Q2 2026, an estimated $232K.
GTS Securities first reported a position in Beam Therapeutics in Q3 2025 and held it in 2 quarters.
GTS Securities's Beam Therapeutics position peaked at $559K in Q3 2025.
277 funds tracked by Wall St. Rank held Beam Therapeutics as of Q2 2026.

Based on GTS Securities's 13F filing for Q2 2026, filed 14 Aug 2026.